Kilpest India is currently trading at Rs. 12.00, up by 0.85 points or 7.62% from its previous closing of Rs. 11.15 on the BSE.
The scrip opened at Rs. 11.00 and has touched a high and low of Rs. 12.00 and Rs. 11.00 respectively.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 24.90 on 21-Jul-2011 and a 52 week low of Rs. 10.20 on 08-Jun-2012.
Last one week high and low of the scrip stood at Rs. 12.47 and Rs. 11.01 respectively. The current market cap of the company is Rs. 7.05 crore.
The promoters holding in the company stood at 41.22% while Non-Institutions held 58.78% stake in the company.
Kilpest India has received an order worth Rs 67.10 lakhs for supply of pesticides to be used in mosquito control programme, from Municipal Corporation of Delhi through HLL Lifecare, Noida.
Earlier in February this year, the company had received orders worth Rs 1.20 crore for supply of pesticides to be used in mosquito control programme, from Directorate of Health Services, Government of Madhya Pradesh.
Kilpest India is one of India’s leading agri-based companies. It has representation in India in the field of agriculture business comprising crop protection products and public health products, bio products, micro-nutrients and mix fertilizers.
| Company Name | CMP |
|---|---|
| Lenskart Solutions | 523.20 |
| Poly Medicure | 1448.60 |
| Laxmi Denta | 195.25 |
| Nureca Ltd. | 260.00 |
| Hemant Surgical Inds | 308.80 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: